Bioventus Inc. (NASDAQ:BVS) Given Consensus Recommendation of "Moderate Buy" by AnalystsMarket Beat·1 day ago, 08:14 AMBVS-0.35%
Aerospace and Auto ICs Propel Niche Equities as Multiple Firms Raise 2026 GuidanceGlobal Report·Sep 1 at 10:13 AMAER-0.88%BZAI-4.33%
Bioventus Inc. (NASDAQ:BVS) Receives Consensus Recommendation of "Buy" from BrokeragesMarket Beat·Aug 9 at 08:14 AMBVS-0.35%
Deal Dispatch: Bending Spoons Acquires Airtable, Bain Capital Buys Gong Cha Global, Salad and Go Bankruptcybenzinga_article·Aug 7 at 05:12 PMDV+0.07%QVCPQ0.00%
Biotech Stocks At 52-Week Highs - BVS, TVTX, ODTX, CRL Climb With Q2 Results, ACRSrttnews·Aug 6 at 08:55 AMACRS+3.28%CRL-1.41%
Bioventus shares are trading higher after the company reported strong Q2 financial results and announced a review of strategic alternatives.benzinga_article·Aug 5 at 03:00 PMBVS-0.35%
BVS: Q2 revenue up 4%, EPS surged, and a strategic review was launched after acquisition interestQuartr·Aug 5 at 12:05 PMBVS-0.35%
Bioventus | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 153.21 MEarnings Watch·Aug 5 at 11:42 AMBVS-0.35%
Bioventus Q2 FY26 GAAP EPS rises to $0.47; revenue increases 4% to $153.2 millionPUBT·Aug 5 at 11:31 AMBVS-0.35%
Bioventus sets second-quarter fiscal 2026 results release, conference callPUBT·Jul 29 at 12:33 PMBVS-0.35%
Biotech Stocks At 52-Week Highs - INCY Rises With Q2 Results, PLSE, SI, BVS, LBRXrttnews·Jul 29 at 08:23 AMBVS-0.35%LBRX+3.86%
Biotech Stocks At 52-Week Highs- CDNA, IART, AGL, BVS, ELVNrttnews·Jul 17 at 09:18 AMIART+0.30%BVS-0.35%
